Mexico- Results of sensitivity analysis on average cost-effectiveness ratio (ACER).
收藏数据链接：
官方服务：
资源简介：
aUnidad de Análisis Económico - 8.4% stage I, 38.5% stage II, 42.5% stage III, 10.6% stage IV [42].b9.7% stage I, 52.7% stage II, 34.8% stage III, 2.8% stage IV [41].c9.4% stage I, 14.2% stage II, 58.0% stage III, 18.4% stage IV [7].dAlternative Case Fatality rates: 0,013 stage I, 0,042 stage II, 0,102 stage III, 0,266 stage IV [35].eMechanical equipment (e.g. mammography machines, CT, X-ray).fAlternative assumptions on effectiveness of awareness interventions (−25%), sensitivity of CBE, and stage shifts of CBE screening.
创建时间：
2015-12-02
